Revvity reported $729M in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Agilent USD 1.88B 43M Jun/2026
Align Technology USD 1.02B 40M Sep/2026
Bio Techne USD 299.71M 21.49M Sep/2026
Bio-Rad Laboratories USD 656.4M 5.4M Sep/2026
Bruker USD 874M 35.5M Sep/2026
Celltrion KRW 1.24T 90B Jun/2026
Charles River Laboratories USD 982.7M 17.3M Sep/2026
Cspc Pharmaceutical CNY 6.47B 355.1M Mar/2026
Danaher USD 6.55B 254M Sep/2026
Dentsply International USD 836M 62M Sep/2026
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Dianthus Therapeutics USD 761K 298K Jun/2026
Divis Laboratories Ltd INR 36.76B 9.18B Sep/2026
Edwards Lifesciences USD 1.72B 20M Sep/2026
Illumina USD 1.17B 10M Sep/2026
Intuitive Surgical USD 3.05B 158.7M Sep/2026
IQVIA Holdings USD 4.43B 60M Sep/2026
Kangmei Pharma CNY 1.19B 106M Jun/2026
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Laboratory Of America USD 3.81B 80M Sep/2026
Medical Developments International AUD 21.57M 12.04M Dec/2025
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Mettler Toledo International USD 1.09B 60M Sep/2026
Myriad Genetics USD 190.7M 9.7M Jun/2026
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
OraSure Technologies USD 26.76M 322K Dec/2025
Organigram Holdings CAD 105.78M 45.99M Jun/2026
Pacific Biosciences Of California USD 44.64M 6.2M Dec/2025
Pharma Mar EUR 54.2M 4.2M Sep/2026
Qiagen NV USD 487.78M 24.66M Sep/2026
Quest Diagnostics USD 3.1B 57M Sep/2026
Quidel USD 618.9M 12M Sep/2026
Repligen USD 209M 5M Sep/2026
Revvity USD 729M 680K Sep/2026
Sartorius EUR 926.3M 14.5M Sep/2026
Sino Biopharmaceutical CNY 19.44B 5.18B Jun/2026
Thermo Fisher Scientific USD 12.14B 147M Sep/2026
Tilray USD 217.51M 74.75M Dec/2025
Waters USD 1.77B 130M Sep/2026
Zealand Pharma A/S 34M 34.92M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 1.78B 50M Sep/2026